Supplementary Table 2 Cytofluorometric analyses of peripheral blood mononuclear cells on day 8 (A) and day 13 (B) of anti-CD4 treatment (data from one representative of three in vivo experiments).

0 ± 0.0

107 ± 9.0

4 ± 0.5

98 ± 2.0

1 ± 0.3

82 ± 3.3

0 ± 0.0

86 ± 7.7

70 ± 5.5

122 ± 1.7

47 ± 5.0

99 ± 1.5

31 ± 1.9^*

93 ± 1.5^*

28 ± 7.2^*

95 ± 0.7^*

21 ± 1.0

162 ± 1.3

27 ± 3.0

110 ± 1.5

33 ± 2.0^*

109 ± 5.0^*

39 ± 3.2^*

111 ± 0.3^*

55 ± 3.2

116 ± 0.8

7 ± 2.5

98 ± 1.5

23 ± 1.7^*

97 ± 1.2^*

8 ± 1.5^*

95 ± 0.7^*

52 ± 7.5

150 ± 0.9

45 ± 8.0

93 ± 3.0

26 ± 4.1

122 ± 2.4

8 ± 1.2^*

121 ± 1.0^*

1 ± 0.3

105 ± 1.9

18 ± 2.0

101 ± 0.5

2 ± 0.3

79 ± 2.4^*

1 ± 0.0

85 ± 3.2^*

Treatment

PBS (n = 3)

W3/25 (n = 4)

OX35 (n = 4)

RIB5/2 (n = 3)

%

MFI

%

MFI

%

MFI

%

MFI

1 ± 0.6

78 ± 1.3

2 ± 1.7

87 ± 4.1

1 ± 0.3

81 ± 3.7

1 ± 0.3

71 ± 1.7

53 ± 2.3

142 ± 0.6

44 ± 2.3

116 ± 3.0^*

39 ± 2.5^*

94 ± 1.0^*

38 ± 1.5^*

96 ± 2.0^*

20 ± 3.8

144 ± 1.5

23 ± 1.7

128 ± 3.2^*

30 ± 7.4

108 ± 1.6^*

41 ± 2.3^*

113 ± 0.9^*

46 ± 1.0

110 ± 1.9

28 ± 2.0^*

109 ± 1.9

25 ± 2.9^*

104 ± 1.6

20 ± 0.9^*

106 ± 0.7

46 ± 0.7

154 ± 0.7

29 ± 3.8^*

144 ± 5.9

23 ± 5.3^*

102 ± 2.6^*

17 ± 2.5^*

116 ± 6.4^*

4 ± 2.5

77 ± 2.5

9 ± 2.0

91 ± 3.5^*

1 ± 0.2

82 ± 2.7

2 ± 0.0

76 ± 1.2